Surrozen: Funding, Investors & Team (Sep 2026)
Surrozen is a biotechnology company that is researching and creating drug candidates that can target the Wnt pathway. They are working on antibodies that can activate the body's natural repair mechanisms in specific tissues, with potential uses in various diseases affecting different parts of the body such as the intestine, liver, eyes, lungs, and nervous system.
Surrozen has raised $193M across 2 funding rounds on record, the most recent an undisclosed round of $175M announced in Mar 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Surrozen Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Surrozen Funding Rounds
Surrozen raised $17.5M in an undisclosed round announced in Apr 2024.
11 months later, an undisclosed round of $175M was announced in Mar 2025.
Surrozen Founders and Leadership Team
No contact details are on record for this team yet.
Surrozen Funding Compared to Other Biotechnology Startups
Surrozen's latest round of $175M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Surrozen in Biotechnology and South San Francisco
Companies Similar to Surrozen
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Surrozen Funding FAQs
What does Surrozen do?
Surrozen is a biotechnology company that is researching and creating drug candidates that can target the Wnt pathway. They are working on antibodies that can activate the body's natural repair mechanisms in specific tissues, with potential uses in various diseases affecting different parts of the body such as the intestine, liver, eyes, lungs, and nervous system.
How much funding has Surrozen raised?
Surrozen has raised $193M across 2 rounds on record. The most recent is an undisclosed round of $175M announced in Mar 2025.
When did Surrozen last raise funding?
Surrozen's most recent funding round on record is an undisclosed round of $175M, announced in Mar 2025.
Who founded Surrozen?
FundedIQ lists Calvin Kuo (Founder) at Surrozen.
Where is Surrozen headquartered?
Surrozen is based in South San Francisco, California, United States.
How many employees does Surrozen have?
Surrozen is in the 51-100 employee band.
How does Surrozen's funding compare to other Biotechnology startups?
Surrozen's latest round of $175M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Surrozen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Surrozen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.